Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 94
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Psychol Health Med ; 22(8): 969-977, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-27855515

RESUMO

The aim of this study was to investigate the feelings of anxiety and satisfaction among 79 primiparas who had uncomplicated pregnancies, at the time of hospital admission and after birth, considering the mode of delivery, analgesia, and pain levels. Questionnaires were completed at admission to the hospital and two months after delivery, using the State-Trait Anxiety Inventory (STAI) state scale and the Labour Agentry Scale. The mean (SD) STAI state score was higher at admission (36.7 (10.7)) than 4 months after childbirth (32.1 (9.7)) (paired Student's t-test, t = 2.93; df = 78; p = .004). However, the postnatal anxiety was not associated with the mode of delivery, epidural or pain. Regarding the satisfaction with the expectations of control during childbirth, the mean (SD) score was higher before childbirth (166.0 (21.8)) than after (157.5 (33.5)) (paired Student's t-test, t = -2.28; df = 77; p = .03). The satisfaction with the childbirth experience was significantly associated with the expectations of childbirth and the mode of delivery, but not with analgesia or pain. The postnatal anxiety was associated with physical health, pain and the Edinburgh Postnatal Depression Scale score during the postpartum period. It is important to consider the temporality of perinatal anxiety in order to understand its causes. Our results indicate that the experience of childbirth was predicted in this sample by the antenatal expectations and delivery outcomes.


Assuntos
Ansiedade/psicologia , Parto/psicologia , Satisfação Pessoal , Adulto , Analgesia Obstétrica/psicologia , Depressão Pós-Parto/psicologia , Feminino , Humanos , Controle Interno-Externo , Dor do Parto/psicologia , Trabalho de Parto , Estudos Longitudinais , Período Pós-Parto/psicologia , Gravidez , Estudos Prospectivos , Estatística como Assunto , Inquéritos e Questionários
2.
Rev Med Suisse ; 13(544-545): 58-60, 2017 Jan 11.
Artigo em Francês | MEDLINE | ID: mdl-28703538

RESUMO

Obstetric medicine is a specialty that addresses maternal health and medical complications during pregnancy. This emerging specialty responds to the increasing need for specialized intervention in cases of high risk pregnancies, at a time when pregnancies can occur at more advanced ages and where advances in therapeutics now allow to consider pregnancy in mothers with chronic illness. Furthermore, medical conditions specific to pregnancy, such as hypertensive disorders of pregnancy or gestational diabetes, are now recognized as emerging risk factors for cardiovascular, metabolic and renal diseases, for which longitudinal care beyond the maternity ward is of critical importance.


La médecine interne obstétricale est une spécialité dédiée à la santé maternelle et aux affections médicales de la grossesse. Il s'agit d'une spécialité novatrice, répondant à la demande croissante d'aide spécialisée dans la prise en charge des grossesses à haut risque, à une époque où l'âge de la grossesse est de plus en plus tardif et où les avancées thérapeutiques permettent d'envisager la grossesse en cas d'affection chronique. De plus, les complications médicales de la grossesse, telles que les hypertensions gravidiques ou le diabète gestationnel, sont désormais reconnues comme des facteurs de risque cardiovasculaires, métaboliques et rénaux émergents, pour lesquelles la continuité des soins à long terme est nécessaire.


Assuntos
Saúde Materna , Obstetrícia/tendências , Equipe de Assistência ao Paciente , Feminino , Humanos , Saúde Materna/normas , Serviços de Saúde Materna/organização & administração , Serviços de Saúde Materna/normas , Mortalidade Materna , Obstetrícia/métodos , Equipe de Assistência ao Paciente/organização & administração , Equipe de Assistência ao Paciente/normas , Gravidez , Complicações na Gravidez/etiologia , Complicações na Gravidez/mortalidade , Complicações na Gravidez/terapia , Resultado do Tratamento
3.
Rev Med Suisse ; 13(580): 1843-1845, 2017 Oct 25.
Artigo em Francês | MEDLINE | ID: mdl-29071834

RESUMO

Out-of-hospital delivery is rare in Switzerland and it accounted for 2,5 % of all the births in 2015. In Switzerland, out-of-hospital childbirth is not subject to any official regulations. It takes place mainly in midwifery units (1,6 %) and at home (0,9 %), by independent midwifes. One in six women needs to be transferred to a hospital because of complications. Perinatal mortality is higher in out-of-hospital childbirth and the hospital is the safest place to give birth. The level of intervention may be lower, maybe because the women choosing to give birth in alternative settings are at lower risk.


L'accouchement extrahospitalier est un phénomène rare en Suisse et concernait 2,5 % des naissances en 2015. En Suisse, il n'est pas soumis à une réglementation officielle. Il a lieu majoritairement en maison de naissance (1,6 %) puis à domicile (0,9 %), par une sage-femme indépendante. Parmi ces parturientes, une femme sur six doit être référée à une équipe hospitalière en raison de complications durant le travail. La mortalité périnatale est plus élevée lors d'un accouchement extrahospitalier, ce qui place l'hôpital comme le lieu le plus sûr pour accoucher. En contrepartie, le niveau d'intervention pourrait être plus bas quand l'accouchement est planifié hors de l'hôpital, mais ceci pourrait être dû au fait que ces femmes sont à bas risque.


Assuntos
Parto Domiciliar , Tocologia , Parto Obstétrico , Feminino , Humanos , Gravidez , Suíça
4.
Lancet ; 385(9987): 2600-5, 2015 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-25863654

RESUMO

BACKGROUND: Macrosomic fetuses are at increased risk of shoulder dystocia. We aimed to compare induction of labour with expectant management for large-for-date fetuses for prevention of shoulder dystocia and other neonatal and maternal morbidity associated with macrosomia. METHODS: We did this pragmatic, randomised controlled trial between Oct 1, 2002, and Jan 1, 2009, in 19 tertiary-care centres in France, Switzerland, and Belgium. Women with singleton fetuses whose estimated weight exceeded the 95th percentile, were randomly assigned (1:1), via computer-generated permuted-block randomisation (block size of four to eight) to receive induction of labour within 3 days between 37(+0) weeks and 38(+6) weeks of gestation, or expectant management. Randomisation was stratified by centre. Participants and caregivers were not masked to group assignment. Our primary outcome was a composite of clinically significant shoulder dystocia, fracture of the clavicle, brachial plexus injury, intracranial haemorrhage, or death. We did analyses by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00190320. FINDINGS: We randomly assigned 409 women to the induction group and 413 women to the expectant management group, of whom 407 women and 411 women, respectively, were included in the final analysis. Mean birthweight was 3831 g (SD 324) in the induction group and 4118 g (392) in the expectant group. Induction of labour significantly reduced the risk of shoulder dystocia or associated morbidity (n=8) compared with expectant management (n=25; relative risk [RR] 0·32, 95% CI 0·15-0·71; p=0·004). We recorded no brachial plexus injuries, intracranial haemorrhages, or perinatal deaths. The likelihood of spontaneous vaginal delivery was higher in women in the induction group than in those in the expectant management group (RR 1·14, 95% CI 1·01-1·29). Caesarean delivery and neonatal morbidity did not differ significantly between the groups. INTERPRETATION: Induction of labour for suspected large-for-date fetuses is associated with a reduced risk of shoulder dystocia and associated morbidity compared with expectant management. Induction of labour does not increase the risk of caesarean delivery and improves the likelihood of spontaneous vaginal delivery. These benefits should be balanced with the effects of early-term induction of labour. FUNDING: Assistance Publique-Hôpitaux de Paris and the University of Geneva.


Assuntos
Parto Obstétrico/estatística & dados numéricos , Macrossomia Fetal/epidemiologia , Trabalho de Parto Induzido/estatística & dados numéricos , Avaliação de Processos e Resultados em Cuidados de Saúde/estatística & dados numéricos , Adulto , Bélgica , Cesárea/estatística & dados numéricos , Distocia/epidemiologia , Distocia/prevenção & controle , Feminino , França , Humanos , Incidência , Complicações do Trabalho de Parto/epidemiologia , Complicações do Trabalho de Parto/prevenção & controle , Gravidez , Suíça , Centros de Atenção Terciária/estatística & dados numéricos
5.
Am J Obstet Gynecol ; 215(5): 604.e1-604.e6, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27342045

RESUMO

BACKGROUND: Choice of delivery route after previous cesarean delivery can be difficult because both trial of labor after cesarean delivery and elective repeat cesarean delivery are associated with risks. The major risk that is associated with trial of labor after cesarean delivery is uterine rupture that requires emergency laparotomy. OBJECTIVE: This study aimed to estimate the occurrence of uterine rupture during trial of labor after cesarean delivery when lower uterine segment thickness measurement is included in the decision-making process about the route of delivery. STUDY DESIGN: In 4 tertiary-care centers, we prospectively recruited women between 34 and 38 weeks of gestation who were contemplating a vaginal birth after a previous single low-transverse cesarean delivery. Lower uterine segment thickness was measured by ultrasound imaging and integrated in the decision of delivery route. According to lower uterine segment thickness, women were classified in 3 risk categories for uterine rupture: high risk (<2.0 mm), intermediate risk (2.0-2.4 mm), and low risk (≥2.5 mm). Our primary outcome was symptomatic uterine rupture, which was defined as requiring urgent laparotomy. We calculated that 942 women who were undergoing a trial of labor after cesarean delivery should be included to be able to show a risk of uterine rupture <0.8%. RESULTS: We recruited 1856 women, of whom 1849 (99%) had a complete follow-up data. Lower uterine segment thickness was <2.0 mm in 194 women (11%), 2.0-2.4 mm in 217 women (12%), and ≥2.5 mm in 1438 women (78%). Rate of trial of labor was 9%, 42%, and 61% in the 3 categories, respectively (P<.0001). Of 984 trials of labor, there were no symptomatic uterine ruptures, which is a rate that was lower than the 0.8% expected rate (P=.0001). CONCLUSION: The inclusion of lower uterine segment thickness measurement in the decision of the route of delivery allows a low risk of uterine rupture during trial of labor after cesarean delivery.


Assuntos
Parto Obstétrico/métodos , Prova de Trabalho de Parto , Ruptura Uterina/epidemiologia , Útero/diagnóstico por imagem , Nascimento Vaginal Após Cesárea , Adulto , Tomada de Decisão Clínica , Feminino , Humanos , Tamanho do Órgão , Gravidez , Estudos Prospectivos , Medição de Risco , Ultrassonografia Pré-Natal , Útero/anatomia & histologia
6.
BMC Med Res Methodol ; 16: 50, 2016 05 04.
Artigo em Inglês | MEDLINE | ID: mdl-27145883

RESUMO

BACKGROUND: Many medical research projects encounter difficulties. The objective of this study was to assess the self-reported frequency of difficulties encountered by medical researchers while conducting research and to identify factors associated with their occurrence. METHODS: The authors conducted a cross-sectional survey in 2010 among principal investigators of 996 study protocols approved by the Research Ethics Committee in Geneva, Switzerland, between 2001 and 2005. The authors asked principal investigators to rate the level of difficulty (1: none, to 5: very great) encountered across the research process. RESULTS: 588 questionnaires were sent back (participation rate 59.0 %). 391 (66.5 %) studies were completed at the time of the survey. Investigators reported that the most frequent difficulties were related to patient enrollment (44.3 %), data collection (26.7 %), data analysis and interpretation (21.5 %), collaboration with caregivers (21.0 %), study design (20.4 %), publication in peer-reviewed journal (20.2 %), hiring of competent study personnel (20.2 %), and getting funding (19.2 %). On average, investigators reported 2.8 difficulties per project (SD 2.8, range 0 to 12). In multivariable analysis, the number of difficulties was higher for studies initiated by public sponsors (vs. private), single center studies (vs. multicenter), and studies about treatment, diagnosis or prognosis (i.e., clinical vs. other studies). CONCLUSIONS: Medical researchers reported substantial logistical difficulties in conducting clinical research.


Assuntos
Seleção de Pacientes , Ensaios Clínicos como Assunto , Estudos Transversais , Pesquisas sobre Atenção à Saúde , Humanos , Análise Multivariada , Fatores de Risco
7.
Cochrane Database Syst Rev ; (5): CD000938, 2016 05 22.
Artigo em Inglês | MEDLINE | ID: mdl-27208913

RESUMO

Editorial note: It has been brought to the authors' attention that there may be an error in the data (Analysis 1.9). This is currently under investigation, and a correction will be made if the data are found to be incorrect. Details can be found in the comments. BACKGROUND: Women with a suspected large-for-dates fetus or a fetus with suspected macrosomia (birthweight greater than 4000 g) are at risk of operative birth or caesarean section. The baby is also at increased risk of shoulder dystocia and trauma, in particular fractures and brachial plexus injury. Induction of labour may reduce these risks by decreasing the birthweight, but may also lead to longer labours and an increased risk of caesarean section. OBJECTIVES: To assess the effects of a policy of labour induction at or shortly before term (37 to 40 weeks) for suspected fetal macrosomia on the way of giving birth and maternal or perinatal morbidity. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 January 2016), contacted trial authors and searched reference lists of retrieved studies. SELECTION CRITERIA: Randomised trials of induction of labour for suspected fetal macrosomia. DATA COLLECTION AND ANALYSIS: Review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We contacted study authors for additional information. For key outcomes the quality of the evidence was assessed using the GRADE approach. MAIN RESULTS: We included four trials, involving 1190 women. It was not possible to blind women and staff to the intervention, but for other 'Risk of bias' domains these studies were assessed as being at low or unclear risk of bias.Compared to expectant management, there was no clear effect of induction of labour for suspected macrosomia on the risk of caesarean section (risk ratio (RR) 0.91, 95% confidence interval (CI) 0.76 to 1.09; 1190 women; four trials, moderate-quality evidence) or instrumental delivery (RR 0.86, 95% CI 0.65 to 1.13; 1190 women; four trials, low-quality evidence). Shoulder dystocia (RR 0.60, 95% CI 0.37 to 0.98; 1190 women; four trials, moderate-quality evidence), and fracture (any) (RR 0.20, 95% CI 0.05 to 0.79; 1190 women; four studies, high-quality evidence) were reduced in the induction of labour group. There were no clear differences between groups for brachial plexus injury (two events were reported in the control group in one trial, low-quality evidence). There was no strong evidence of any difference between groups for measures of neonatal asphyxia; low five-minute infant Apgar scores (less than seven) or low arterial cord blood pH (RR 1.51, 95% CI 0.25 to 9.02; 858 infants; two trials, low-quality evidence; and, RR 1.01, 95% CI 0.46 to 2.22; 818 infants; one trial, moderate-quality evidence, respectively). Mean birthweight was lower in the induction group, but there was considerable heterogeneity between studies for this outcome (mean difference (MD) -178.03 g, 95% CI -315.26 to -40.81; 1190 infants; four studies; I(2) = 89%). In one study with data for 818 women, third- and fourth-degree perineal tears were increased in the induction group (RR 3.70, 95% CI 1.04 to 13.17).For outcomes assessed using GRADE, we based our downgrading decisions on high risk of bias from lack of blinding and imprecision of effect estimates. AUTHORS' CONCLUSIONS: Induction of labour for suspected fetal macrosomia has not been shown to alter the risk of brachial plexus injury, but the power of the included studies to show a difference for such a rare event is limited. Also antenatal estimates of fetal weight are often inaccurate so many women may be worried unnecessarily, and many inductions may not be needed. Nevertheless, induction of labour for suspected fetal macrosomia results in a lower mean birthweight, and fewer birth fractures and shoulder dystocia. The unexpected observation in the induction group of increased perineal damage, and the plausible, but of uncertain significance, observation of increased use of phototherapy, both in the largest trial, should also be kept in mind.Findings from trials included in the review suggest that to prevent one fracture it would be necessary to induce labour in 60 women. Since induction of labour does not appear to alter the rate of caesarean delivery or instrumental delivery, it is likely to be popular with many women. In settings where obstetricians can be reasonably confident about their scan assessment of fetal weight, the advantages and disadvantages of induction at or near term for fetuses suspected of being macrosomic should be discussed with parents.Although some parents and doctors may feel the evidence already justifies induction, others may justifiably disagree. Further trials of induction shortly before term for suspected fetal macrosomia are needed. Such trials should concentrate on refining the optimum gestation of induction, and improving the accuracy of the diagnosis of macrosomia.


Assuntos
Macrossomia Fetal , Trabalho de Parto Induzido , Peso ao Nascer , Neuropatias do Plexo Braquial/prevenção & controle , Parto Obstétrico , Distocia/prevenção & controle , Feminino , Humanos , Complicações do Trabalho de Parto/prevenção & controle , Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto , Conduta Expectante
8.
Rev Med Suisse ; 12(500): 39-40, 42-3, 2016 Jan 13.
Artigo em Francês | MEDLINE | ID: mdl-26946702

RESUMO

The Swiss law on Assisted Reproductive Techniques (LPMA) has been modified in order to authorize preimplantation genetic diagnosis (PGD). PGD has been performed for 20 years. Switzerland is one of the last european countries where it is still prohibited. As a result, couples carrying a severe inherited disease and infertile couples with recurrent implantation failure or miscarriage have to cross the borders in order to have access to the appropriate treatments. Despite the recent popular approval to change the Constitution, the new LPMA cannot be implemented as the opponants have launched a referendum in order to obtain a more restrictive law. If they succeed, the affected couples will be left with a scientifically obsolete law that will not allow them to have access to an effective and compassionate treatment.


Assuntos
Acessibilidade aos Serviços de Saúde , Diagnóstico Pré-Implantação/métodos , Técnicas de Reprodução Assistida/legislação & jurisprudência , Feminino , Humanos , Gravidez , Suíça
9.
Rev Med Suisse ; 11(456-457): 68-71, 2015 Jan 14.
Artigo em Francês | MEDLINE | ID: mdl-25799654

RESUMO

Pregnancies in older women are increasing. These women often have comorbidities. These pregnancies, spontaneous, after IVF or egg donation are at high risk of complications, particularly hypertension, preeclampsia, gestational diabetes, low birth weight, and delivery by cesarean section. Women with Turner syndrome can conceive only by egg donation and are at very high risk of cardiovascular complications. Screening of these comorbidities and pregnancy care by maternal-fetal medicine specialists, with pluridisciplinary collaboration, are mandatory. Delivery in a tertiary care center able to offer optimal care to the mothers and their newborns is recommended.


Assuntos
Doação de Oócitos , Cuidado Pré-Natal , Adulto , Fatores Etários , Feminino , Humanos , Gravidez , Fatores de Risco
10.
Reprod Biomed Online ; 28(2): 216-24, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24365018

RESUMO

This study determined whether anti-Müllerian hormone (AMH) concentration influences the time necessary to conceive a live-born child--effective time to pregnancy (eTTP)--in a population of women who conceived naturally. This is an observational study of 87 women with a planned spontaneous pregnancy resulting in a live birth. eTTP was assessed retrospectively by a questionnaire and AMH was measured in a frozen serum sample from first trimester of pregnancy. eTTP was correlated with age (r=-0.24, P=0.02), but not with AMH (r=-0.10) or body mass index (r=0.05). With logistic regressions, the only variable that affected the probability of pregnancy within 3 or 6 months was age, irrespective of whether an AMH concentration limit of 1.0 ng/ml or 2.0 ng/ml was chosen. In conclusion, this study suggests that there is no relationship between AMH concentration and eTTP and therefore speaks against determining AMH in women who are not infertile for the purpose of predicting their chances of pregnancy. The findings are concordant with previous reports describing AMH as a quantitative but not a qualitative marker of ovarian reserve and therefore does not reflect a woman's ability to become pregnant. Anti-Müllerian hormone (AMH) is secreted by small growing ovarian follicles and reflects a woman's ovarian reserve - the number of primordial follicles at a given time. AMH concentrations has been extensively studied in infertile women but there are only scarce data on AMH in non-infertile women. Our objective was to determine whether AMH concentrations influence the time necessary to conceive a live-born child - also called effective time to pregnancy (eTTP) - in a population of women who conceived naturally. We conducted an observational study between 2007 and 2009 in which we assessed eTTP retrospectively in 87 women who had delivered a live-born child and measured AMH in a frozen blood sample collected during the first trimester of pregnancy. The results of our study show, as expected, a decrease of AMH concentrations as age increases but no relationship between AMH and eTTP. In conclusion, our study results suggest AMH concentrations do not influence the time necessary to conceive a live-born child spontaneously and therefore speak against determining AMH in women who are not infertile for the purpose of predicting their chances of pregnancy. Our findings are concordant with previous reports describing AMH as a quantitative but not a qualitative marker of ovarian function that does therefore not reflect a woman's ability to become pregnant.


Assuntos
Hormônio Antimülleriano/sangue , Tempo para Engravidar/fisiologia , Índice de Massa Corporal , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Modelos Logísticos , Gravidez , Estudos Retrospectivos , Inquéritos e Questionários
11.
BMC Pregnancy Childbirth ; 14: 83, 2014 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-24564746

RESUMO

BACKGROUND: The occipito-posterior (OP) fetal head position during the first stage of labour occurs in 10-34% of cephalic presentations. Most will spontaneous rotate in anterior position before delivery, but 5-8% of all births will persist in OP position for the third stage of labour. Previous observations have shown that this can lead to an increase of complications, such as an abnormally long labour, maternal and fetal exhaustion, instrumental delivery, severe perineal tears, and emergency caesarean section. Usual care in the case of diagnosis of OP position is an expectant management. However, maternal postural techniques have been reported to promote the anterior position of the fetal head for delivery. A Cochrane review reported that these maternal positions are well accepted by women and reduce back pain. However, the low sample size of included studies did not allow concluding on their efficacy on delivery outcomes, particularly those related to persistent OP position. Our objective is to evaluate the efficacy of maternal position in the management of OP position during the first stage of labour. METHODS/DESIGN: A randomised clinical trial is ongoing in the maternity unit of the Geneva University Hospitals, Geneva, Switzerland. The unit is the largest in Switzerland with 4,000 births/year. The trial will involve 438 women with a fetus in OP position, confirmed by sonography, during the first stage of the labour. The main outcome measure is the position of the fetal head, diagnosed by ultrasound one hour after randomisation. DISCUSSION: It is important to evaluate the efficacy of maternal position to correct fetal OP position during the first stage of the labour. Although these positions seem to be well accepted by women and appear easy to implement in the delivery room, the sample size of the last randomised clinical trial published in 2005 to evaluate this intervention had insufficient power to demonstrate clear evidence of effectiveness. If the technique demonstrates efficacy, it would reduce the physical and psychological consequences of complications at birth related to persistent OP position. TRIAL REGISTRATION: ClinicalTrials.gov, http://www.clinicaltrials.gov: (no. NCT01291355).


Assuntos
Apresentação no Trabalho de Parto , Trabalho de Parto , Posicionamento do Paciente , Postura , Versão Fetal/métodos , Feminino , Cabeça/diagnóstico por imagem , Cabeça/embriologia , Humanos , Recém-Nascido , Gravidez , Resultado da Gravidez , Ultrassonografia Pré-Natal
12.
Arch Gynecol Obstet ; 289(4): 903-9, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24385286

RESUMO

Tocolysis is an important treatment in the improvement of outcome in preterm labor and preterm birth, provided that its use follows clear evidence-based recommendations. In this expert opinion, the most recent evidence about efficacy and side effects of different tocolytics is being reviewed and evidence-based recommendation about diagnosis and treatment of preterm labor is given. Further aspects such as progesterone administration or antibiotic treatment for the prevention of preterm birth are included. Our review demonstrates that an individualized choice of different tocolytics and additional treatments is necessary to improve short- and long-term neonatal outcome in preterm labor and preterm birth.


Assuntos
Trabalho de Parto Prematuro/tratamento farmacológico , Nascimento Prematuro/prevenção & controle , Tocólise , Tocolíticos/uso terapêutico , Antibacterianos/uso terapêutico , Repouso em Cama , Bloqueadores dos Canais de Cálcio/uso terapêutico , Medida do Comprimento Cervical , Contraindicações , Inibidores de Ciclo-Oxigenase/uso terapêutico , Aprovação de Drogas , Feminino , Fenoterol/uso terapêutico , Ruptura Prematura de Membranas Fetais , Hexoprenalina/uso terapêutico , Humanos , Recém-Nascido , Kalanchoe , Primeira Fase do Trabalho de Parto , Sulfato de Magnésio/uso terapêutico , Doadores de Óxido Nítrico/uso terapêutico , Fitoterapia , Gravidez , Progesterona/uso terapêutico , Progestinas/uso terapêutico , Receptores de Ocitocina/antagonistas & inibidores , Ultrassonografia Pré-Natal
13.
Rev Med Suisse ; 9(403): 1938-40, 1942, 2013 Oct 23.
Artigo em Francês | MEDLINE | ID: mdl-24245015

RESUMO

Obstetrical emergencies may represent extremely critical situations with potential dramatic maternal and neonatal consequences. These situations should be managed by an effective and experienced multidisciplinary staff. Simulation allows a regular and repeated practice of these situations with no risk to patient safety and the possibility to analyse participants' performances in a group. This review describes different obstetrical simulation methods and summarizes the evidence for its efficiency in obstetric practice.


Assuntos
Parto Obstétrico/educação , Manequins , Obstetrícia/educação , Feminino , Humanos , Gravidez
14.
Cytotherapy ; 14(2): 215-22, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22136296

RESUMO

BACKGROUND AIMS: Umbilical cord blood (UCB) is a source of hematopoietic stem cells that initially was used exclusively for the hematopoietic reconstitution of pediatric patients. It is now suggested for use for adults as well, a fact that increases the pressure to obtain units with high cellularity. Therefore, the optimization of UCB processing is a priority. METHODS: The present study focused on parameters influencing total nucleated cell (TNC), mononucleated cell (MNC) and CD34+ cell (CD34C) recovery after routine volume reduction of 1553 UCB units using hydroxyethyl starch-induced sedimentation with an automated device, under routine laboratory conditions. RESULTS: We show that the unit volume rather than the TNC count significantly affects TNC, MNC and CD34C processing efficiency (PEf), and this in a non-linear fashion: when units were sampled according to the collection volume, including pre-loaded anticoagulant (gross volume), PEf increased up to a unit volume of 110-150 mL and decreased thereafter. Thus units with initial gross volumes < 90 mL and > 170 mL similarly exhibited a poor PEf. CONCLUSIONS: These data identify unit gross volume as a major parameter influencing PEf and suggest that fractionation of large units should be contemplated only when the resulting volume of split units is > 90 mL.


Assuntos
Técnicas de Cultura de Células/métodos , Sangue Fetal/citologia , Células-Tronco Hematopoéticas/citologia , Leucócitos Mononucleares/citologia , Antígenos CD34/imunologia , Sedimentação Sanguínea , Humanos , Derivados de Hidroxietil Amido/química , Linfócitos T/citologia , Linfócitos T/imunologia
15.
Cochrane Database Syst Rev ; (3): CD001233, 2012 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-22419277

RESUMO

BACKGROUND: Mechanical methods were the first methods developed to ripen the cervix and induce labour. During recent decades they have been substituted by pharmacological methods. Potential advantages of mechanical methods, compared with pharmacological methods, may include simplicity of preservation, lower cost and reduction of the side effects. OBJECTIVES: To determine the effects of mechanical methods for third trimester cervical ripening or induction of labour in comparison with placebo/no treatment, prostaglandins (vaginal and intracervical prostaglandin E2 (PGE2), misoprostol) and oxytocin. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2011) and bibliographies of relevant papers. We updated this search on 16 January 2012 and added the results to the awaiting classification section of the review. SELECTION CRITERIA: Clinical trials comparing mechanical methods used for third trimester cervical ripening or labour induction with methods listed above it on a predefined list of methods of labour. A comparison with amniotomy will be added, should this comparison be made in future trials.Different types of intervention have been considered as mechanical methods: (1) introduction of laminaria tents, or their synthetic equivalent (Dilapan), into the cervical canal; (2) the introduction of a catheter through the cervix into the extra-amniotic space, with or without traction; (3) use of a catheter to inject fluidsin the extra-amniotic spaceIn addition, we made other comparisons: (1) specific mechanical methods (balloon catheter and laminaria tents) compared with any prostaglandins or with oxytocin; (2) addition of prostaglandins or oxytocin to mechanical methods compared with prostaglandins alone. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion and assessed risk of bias. Two review authors independently extracted data. MAIN RESULTS: For this update we have included a further 27 studies. The review includes 71 randomised controlled trials (total of 9722 women), ranging from 39 to 588 women per study. Most studies reported on caesarean section, all other outcomes are based on substantially fewer women. Four additional studies are ongoing.Mechanical methods versus no treatment: one study (48 woman) reported on women who did not achieve vaginal delivery within 24 hours (risk ratio (RR) 0.90; 95% confidence interval (CI) 0.64 to 1.26). The risk of caesarean section was similar between groups (six studies; 416 women, RR 1.00; 95% CI 0.76 to 1.30). There were no cases of severe neonatal and maternal morbidity.Mechanical methods versus vaginal PGE2 (17 studies;1894 woman): The proportion of women who did not achieve vaginal delivery within 24 hours was not significantly different (three studies; 586 women RR 1.72; 95% CI 0.90 to 3.27); however, for the subgroup of multiparous women the risk of not achieving delivery within 24 hours was higher (one study; 147 women RR 4.38, 95% CI 1.74 to 10.98), with no increase in caesarean sections (RR 1.19, 95% CI 0.62-2.29). Compared with intracervical PGE2 (14 studies;1784 women and misoprostol there was no significant difference in the proportion of women not achieving vaginal delivery within 24 hours.Mechanical methods reduced the risk of hyperstimulation with fetal heart rate changes when compared with vaginal prostaglandins: vaginal PGE2 (eight studies; 1203 women, RR 0.16; 95% CI 0.06 to 0.39) and misoprostol (3% versus 9%) (nine studies; 1615 women, RR 0.37; 95% CI 0.25 to 0.54). Risk of caesarean section between mechanical methods and prostaglandins was comparable. Serious neonatal and maternal morbidity were infrequently reported and did not differ between the groups.Mechanical methods compared with induction with oxytocin (reduced the risk of caesarean section (five studies; 398 women, RR 0.62; 95% CI 0.42 to 0.90). The likelihood of vaginal delivery within 24 hours was not reported. Hyperstimulation with fetal heart rate changes was reported in one study (200 participants), and did not differ. There were no reported cases of severe maternal or neonatal morbidity. AUTHORS' CONCLUSIONS: Induction of labour using mechanical methods results in similar caesarean section rates as prostaglandins, for a lower risk of hyperstimulation. Mechanical methods do not increase the overall number of women not delivered within 24 hours, however the proportion of multiparous women who did not achieve vaginal delivery within 24 hours was higher when compared with vaginal PGE2. Compared with oxytocin, mechanical methods reduce the risk of caesarean section.


Assuntos
Cateterismo/métodos , Maturidade Cervical , Trabalho de Parto Induzido/métodos , Laminaria , Ocitócicos , Colo do Útero , Dinoprostona , Feminino , Humanos , Misoprostol , Ocitocina , Pessários , Polímeros , Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto
16.
J Perinat Med ; 40(5): 469-74, 2012 May 13.
Artigo em Inglês | MEDLINE | ID: mdl-22945271

RESUMO

OBJECTIVE: Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose. We aimed to assess side effects and tolerance of ferric carboxymaltose compared to i.v. iron sucrose in pregnant women. METHODS: We performed a retrospective analysis of 206 pregnant women who were treated either with ferric carboxymaltose or iron sucrose for iron-deficiency anemia with intolerability to oral iron substitution, or insufficient hemoglobin increase after oral iron treatment, or need for rapid hemoglobin reconstitution. Primary endpoint was to evaluate the maternal safety and tolerability. Secondary endpoint was to assess efficacy of the treatment and exclude safety concerns for the fetus. RESULTS: The incidence of drug-related adverse events was low and mostly mild in both groups. Mild adverse events occurred in 7.8% for ferric carboxymaltose and in 10.7% for iron sucrose. The mean rise of hemoglobin value was 15.4 g/L for ferric carboxymaltose and 11.7 g/L for iron sucrose. CONCLUSION: Ferric carboxymaltose administration in pregnant women is well tolerated and is not associated with any relevant clinical safety concerns. Ferric carboxymaltose has a comparable safety profile to iron sucrose but offers the advantage of a much higher iron dosage at a time reducing the need for repeated applications and increasing patients' comfort. Ferric carboxymaltose is the drug of choice, if i.v. iron treatment becomes necessary in the second or third trimester of pregnancy.


Assuntos
Anemia/tratamento farmacológico , Compostos Férricos/administração & dosagem , Ácido Glucárico/administração & dosagem , Hematínicos/administração & dosagem , Maltose/análogos & derivados , Complicações Hematológicas na Gravidez/tratamento farmacológico , Administração Intravenosa , Adolescente , Adulto , Feminino , Óxido de Ferro Sacarado , Humanos , Maltose/administração & dosagem , Pessoa de Meia-Idade , Gravidez , Estudos Retrospectivos , Adulto Jovem
17.
Arch Gynecol Obstet ; 286(2): 277-81, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22543752

RESUMO

INTRODUCTION: Antenatal maternal administration of corticosteroids has been shown to reduce morbidity and mortality rates in preterm delivery. Threatened spontaneous or medically indicated preterm delivery for maternal or fetal indications between 24 and 34 weeks of gestation with unknown fetal lung maturity status are indications for antenatal corticosteroid administration. Recent studies have challenged current practice of antenatal glucocorticoid use. The goal of this expert letter is to provide recommendations based for the clinical use of antenatal glucocorticoids based on the current evidence from published studies. METHODS: The published literature (PubMed search), as well as the recommendations of other national societies, has been searched and taken into consideration for these recommendations. RESULTS/CONCLUSIONS: The standard regimen of antenatal corticosteroids involves a single course of 2 × 12 mg betamethasone administered intramuscularly within 24 h. The administration of corticosteroids usually is performed between 24 and 34 weeks gestation. However, under particular circumstances it may be beneficial even at 23 weeks and at 35-36 weeks of gestation. The evidence to date is clearly against the routine administration of multiple antenatal steroid courses. In special clinical situations, a second course of betamethasone ("rescue course") may be justifiable. Tocolysis during administration of steroids is not routinely indicated in the absence of contractions, cervical shortening or rupture of membranes.


Assuntos
Corticosteroides/administração & dosagem , Pulmão/efeitos dos fármacos , Pulmão/crescimento & desenvolvimento , Guias de Prática Clínica como Assunto , Contraindicações , Feminino , Maturidade dos Órgãos Fetais/efeitos dos fármacos , Humanos , Recém-Nascido , Gravidez , Terceiro Trimestre da Gravidez , Síndrome do Desconforto Respiratório do Recém-Nascido/prevenção & controle
18.
Neuro Endocrinol Lett ; 33(2): 133-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22592193

RESUMO

OBJECTIVES: During implantation, human trophoblastic cells have to proliferate, migrate and invade pregnant uterus. A natural product of cruciferous vegetables, 3,3'-diindolylmethane (DIM), is known to induce some stress response genes (such as glucose-regulated protein 78 kDa (GRP78)) and to have anti-invasive and pro-apoptotic effects on tumor cells. Therefore, we have investigated the potential effect of DIM on invasive extravillous cytotrophoblasts (evCTBs) cells. MATERIALS AND METHODS: evCTBs were purified from first trimester trophoblasts and cultured in presence or not of DIM for 48h. In order to evaluate invasive properties of cells, they were seeded on collagen-coated insert following boyden chamber principle and matrix metalloproteinases (MMPs) and GRP78 expression was evaluated by qPCR. RESULTS: We showed that DIM decreases (p=0.013) invasive properties of evCTBs. In parallel, we determined that MMP-2, -7 and -9 which are involved in evCTBs invasion and known to be regulated by DIM, are not affected by DIM in evCTBs. In contrast, MMP-1 mRNA is induced (p=0.03) and MMP-12 is decreased (p=0.01) in DIM treated cells. Moreover, DIM treatment does not affect GRP78 mRNA expression in evCTBs. CONCLUSIONS: Collectively, the present results provide evidence that DIM does not impact evenly on evCTBs and cancer cells.


Assuntos
Anticarcinógenos/farmacologia , Movimento Celular/efeitos dos fármacos , Indóis/farmacologia , Trofoblastos/efeitos dos fármacos , Trofoblastos/metabolismo , Células Cultivadas , Chaperona BiP do Retículo Endoplasmático , Feminino , Expressão Gênica/efeitos dos fármacos , Proteínas de Choque Térmico/biossíntese , Humanos , Metaloproteinases da Matriz/biossíntese , Gravidez
19.
Neuro Endocrinol Lett ; 33(4): 406-11, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22936257

RESUMO

OBJECTIVES: Preeclampsia is a specific pregnancy disorder which could be due, at least in part, to impaired invasion of trophoblastic cells. Since matrix metalloproteinases (MMPs) are the predominant proteases involved in trophoblastic invasion, we investigated and compared expression of MMP-1, 2, 7, 9 and 12 of cytotrophoblastic cells (CTB) purified from preeclamptic (PE) placentas to control CTB. MATERIAL AND METHODS: In order to evaluate invasive properties of cells, purified CTB were seeded on collagen-coated insert following boyden chamber principle and matrix metalloproteinases (MMPs) expression was evaluated by qPCR. RESULTS: Our results showed that PE CTB are less invasive than control CTB in vitro. In parallel, expression of MMPs, except for MMP-2, tends to be decreased in PE CTB compared to control CTB. CONCLUSION: At the exception of MMP-2, this study confirms the importance of MMPs in development of PE.


Assuntos
Metaloproteases/metabolismo , Placenta/enzimologia , Pré-Eclâmpsia/enzimologia , Trofoblastos/enzimologia , Células Cultivadas , Feminino , Humanos , Metaloproteases/classificação , Metaloproteases/genética , Pré-Eclâmpsia/fisiopatologia , Gravidez , Terceiro Trimestre da Gravidez/metabolismo , RNA Mensageiro/análise
20.
Rev Med Suisse ; 13(580): 1819, 2017 Oct 25.
Artigo em Francês | MEDLINE | ID: mdl-29071829
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA